[HTML][HTML] Targeting PI3K/AKT/mTOR signaling pathway as a radiosensitization in head and neck squamous cell carcinomas

YC Su, WC Lee, CC Wang, SA Yeh, WH Chen… - International Journal of …, 2022 - mdpi.com
Globally, there are over half a million new patients with head and neck squamous cell
carcinomas (HNSCC) every year. The current therapeutic approaches to HNSCC are …

[HTML][HTML] Advancements of radiotherapy for recurrent head and neck cancer in modern era

S Zhang, N Zeng, J Yang, J He, F Zhu, W Liao… - Radiation …, 2023 - Springer
Head and neck cancer is a kind of cancer which can be eradicated from radical radiation
therapy. However, with best efforts, nearly 40% patients will experience locoregional …

[HTML][HTML] PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy

FC Chuang, CC Wang, JH Chen, TZ Hwang, SA Yeh… - PLoS …, 2021 - journals.plos.org
Approximately 500,000 new cases of head and neck squamous cell carcinoma (HNSCC)
are reported annually. Radiation therapy is an important treatment for oral squamous cell …

[HTML][HTML] Taxane-cisplatin-fluorouracil as induction chemotherapy for advanced head and neck cancer: a meta-analysis of the 5-year efficacy and safety

X Qian, C Ma, TK Hoffmann, AM Kaufmann, AE Albers - Springerplus, 2015 - Springer
Background The objective of this study was to compare the efficacy and safety of taxane
(docetaxel or paclitaxel), cisplatin, and fluorouracil (Tax-PF) with cisplatin plus fluorouracil …

Predicting survival after irradiation for brain metastases from head and neck cancer

D Rades, L Dziggel, SG Hakim, V Rudat, S Janssen… - In Vivo, 2015 - iv.iiarjournals.org
Aim: Patients with cerebral metastases from head and neck cancer are not common. This
study aimed to create an instrument for estimating survival in this particular group of patients …

Synergistic effect of honokiol and 5‐fluorouracil on apoptosis of oral squamous cell carcinoma cells

N Ji, L Jiang, P Deng, H Xu, F Chen… - Journal of Oral …, 2017 - Wiley Online Library
Background 5‐Fluorouracil (5‐FU) is an essential chemotherapeutic agent for oral
squamous cell carcinoma (OSCC). However, toxic side effects have limited its role in OSCC …

The oncological outcome and influence of neoadjuvant chemotherapy on the surgery in the resectable and locally advanced oral squamous cell carcinoma

X Su, Q Liu, J Li, C Zhang, Z Xue, C He… - Cancer Management …, 2019 - Taylor & Francis
Aim The role of neoadjuvant chemotherapy (NCT) in the treatment of advanced oral
squamous cell carcinoma (OSCC) is still controversial. Especially, there are still few studies …

[PDF][PDF] Snail-induced CD44high cells in HNSCC with high ABC transporter capacity exhibit potent resistance to cisplatin and docetaxel

M Hashikata, H Shigeishi, G Okui, K Yamamoto… - Int J Clin Exp …, 2016 - e-century.us
CD44high head and neck squamous cell carcinoma (HNSCC) cells with cancer stem cell
(CSC)-like properties have been speculated to be involved in resistance to apoptosis …

[PDF][PDF] Role of Neoadjuvant Chemotherapy in Oral Cavity SCC: A Surgical Oncologists Experience at Tertiary Care Institute

D Patel, E Saldanha, B Joseph, S Ghosh… - European Journal of …, 2021 - researchgate.net
Abstract Oral Squamous Cell Carcinoma (OSCC) is a common malignant head and neck
tumor. The mainstay treatment of OSCC is surgery-centered multimodality therapy …

[PDF][PDF] 选择性动脉灌注化疗在口腔癌治疗中的进展

黄桂林 - Journal of Oral and Maxillofacial Surgery, 2015 - journal06.magtech.org.cn
选择性动脉灌注化疗在口腔癌治疗中的进展 Page 1 专家论坛 选择性动脉灌注化疗在口腔癌治疗
中的进展 黄桂林 (遵义医学院附属口腔医院口腔颂面外科r头颈肿瘤治疗组,贵州遵义563000) [摘要 …